For HBP1, we would suggest that decreased HBP1 expression might contribute to interruption of senescence and the deregulation of some signaling pathways (Wnt, EGF receptor) that are linked to a poor prognosis in breast and other cancers. The gene discussed is HBP1; the disease is cancer.